Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB)
- PMID: 40448889
- DOI: 10.1007/s10096-025-05177-7
Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB)
Abstract
Background: Extrapulmonary tuberculosis (EPTB) poses a diagnostic challenge due to its paucibacillary nature and low diagnostic yield of traditional methods. Molecular diagnostic tools like Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB offer promising alternatives for the rapid and higher detection rates for pulmonary TB samples. However, the yield of these newly introduced molecular tests on extra-pulmonary samples requires country-specific evaluation and comparative analysis.
Methodology: This study evaluated the diagnostic performance of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays in detecting EPTB on 211 clinical specimens collected at a tertiary care centre of central India. The assays' sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPP) were compared against a composite reference standard.
Results: Xpert MTB/RIF Ultra exhibited the highest sensitivity (50%) for EPTB detection, outperforming the standard GeneXpert MTB/RIF (29.4%) and Truenat MTB (35.3%), with comparable specificity across all three assays. Among the specimen types, pus samples demonstrated the highest (value) diagnostic yield. These findings highlight the superior diagnostic capabilities of Xpert MTB/RIF Ultra, particularly in paucibacillary cases.
Conclusion: Xpert Ultra demonstrates superior sensitivity for EPTB detection compared to Xpert MTB/RIF and Truenat MTB, making it a promising tool to enhance diagnostic accuracy in paucibacillary TB. Its adoption as a standard diagnostic method could significantly improve EPTB management. These findings advocate for integrating advanced molecular diagnostics into routine tuberculosis workflows to reduce diagnostic delays and improve patient outcomes.
Clinical trail number: Not applicable.
Keywords: Diagnostic accuracy; Extrapulmonary tuberculosis (EPTB); Molecular diagnostics; Truenat MTB; Xpert MTB/RIF; Xpert MTB/RIF Ultra.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Diagnosis of extrapulmonary tuberculosis by GeneXpert MTB/RIF Ultra assay.Expert Rev Mol Diagn. 2023 Jul-Dec;23(7):561-582. doi: 10.1080/14737159.2023.2223980. Epub 2023 Jun 23. Expert Rev Mol Diagn. 2023. PMID: 37318829
-
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD012768. doi: 10.1002/14651858.CD012768.pub3. Cochrane Database Syst Rev. 2021. PMID: 33448348 Free PMC article.
-
Multi-centric evaluation of Truenat MTB and MTB-RIF Dx assays for diagnosis of extrapulmonary tuberculosis.Sci Rep. 2024 Jul 8;14(1):15680. doi: 10.1038/s41598-024-64688-z. Sci Rep. 2024. PMID: 38977729 Free PMC article.
-
Low diagnostic accuracy of Xpert MTB/RIF assay for extrapulmonary tuberculosis: A multicenter surveillance.Sci Rep. 2019 Dec 6;9(1):18515. doi: 10.1038/s41598-019-55112-y. Sci Rep. 2019. PMID: 31811239 Free PMC article.
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Sep 6;9:CD013359. doi: 10.1002/14651858.CD013359.pub3. PMID: 32853411 Free PMC article. Updated.
References
-
- Global Tuberculosis Report (2024) https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globa...
-
- Training Module on Extrapulmonary TB– Central Tuberculosis Division https://tbcindia.mohfw.gov.in/2023/06/06/training-module-on-extrapulmona...
-
- Chakravorty S et al (2017) The new Xpert MTB/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to Rifampin in an assay suitable for Point-of-Care testing. mBio 8. https://doi.org/10.1128/mbio.00812-17
LinkOut - more resources
Full Text Sources